Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/27/2003 | US20030057258 Nondestructive inspection method |
03/27/2003 | US20030057193 Method for forming a via hole, flexible wiring board using the method, and method for producing the flexible wiring board |
03/27/2003 | US20030057109 Hydrogen sensor includes a pump cell and a measuring cell; hydrogen diffusion through the diffusion-limiting barrier is controlled by a Knudsen diffusion mechanism at higher hydrogen concentrations; use in fuel cell applications |
03/27/2003 | US20030057108 Reduced out-of-warm-up baseline drift for chemical, electrochemical and enzyme sensors, by exposing the sensor and the calibrating solution to an elevated temperature for a given time period, and then exposing to a lower temperature |
03/27/2003 | US20030057094 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field |
03/27/2003 | US20030056581 Apparatus and method for analyzing fluids |
03/27/2003 | US20030056576 Method for evaluating a test fluid |
03/27/2003 | US20030056570 Sensor for detecting inflammable gases |
03/27/2003 | US20030056569 Device, method and use of an odor detection unit for examining and/or recording |
03/27/2003 | US20030056568 Gas seep detection |
03/27/2003 | US20030056567 Apparatus and method for measurement of coefficient of restitution and contact time |
03/27/2003 | CA2708411A1 Compositions and methods for the diagnosis and treatment of tumor |
03/27/2003 | CA2708349A1 Compositions and methods for the diagnosis and treatment of tumor |
03/27/2003 | CA2476995A1 Method of detecting cellular immunity and application thereof to drugs |
03/27/2003 | CA2472023A1 Method for evaluating a patient's biological condition |
03/27/2003 | CA2461352A1 Use of hcv core antigen assay for screening of anti-viral compounds |
03/27/2003 | CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness |
03/27/2003 | CA2460845A1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
03/27/2003 | CA2460817A1 A method for identifying effector molecules for gene network integration |
03/27/2003 | CA2460812A1 Lipid-associated molecules |
03/27/2003 | CA2460808A1 Immune response associated proteins |
03/27/2003 | CA2460771A1 Method for determining the presence of bacteria resistant to cell lysing antibiotics |
03/27/2003 | CA2460721A1 Genetic analysis for stratification of cancer risk |
03/27/2003 | CA2460713A1 Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease |
03/27/2003 | CA2460700A1 Asparagine hydroxylation of the cad domain of a hif protein |
03/27/2003 | CA2460629A1 A method and kit for the measurement of the activation of basophils induced by allergen to determine hypersensitivity |
03/27/2003 | CA2460616A1 Diagnosis and treatment of early pre-type 1 diabetes utilizing glial fibrillary acidic protein |
03/27/2003 | CA2460568A1 Preparation of highly-purified plasma membranes |
03/27/2003 | CA2460526A1 New landmarks and use thereof |
03/27/2003 | CA2460317A1 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets |
03/27/2003 | CA2460151A1 Cytokine receptor |
03/27/2003 | CA2460130A1 Method for detecting sepsis |
03/27/2003 | CA2460128A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter |
03/27/2003 | CA2460120A1 Compositions and methods for the diagnosis and treatment of tumor |
03/27/2003 | CA2460073A1 Embossed test strip system |
03/27/2003 | CA2459972A1 Differential diagnosis of disorders of iron metabolism by means of three independent parameters and recommendations for the treatment of these disorders of iron metabolism |
03/27/2003 | CA2459761A1 Device and method for concentration and detection of pathogenic germs from blood products and/or their derivatives |
03/27/2003 | CA2459219A1 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
03/27/2003 | CA2459140A1 Protein modification and maintenance molecules |
03/27/2003 | CA2459022A1 Neurotransmission-associated proteins |
03/27/2003 | CA2458303A1 Brain expressed cap-2 gene and protein associated with bipolar disorder |
03/27/2003 | CA2457156A1 Clinical trial method for caries treatment agents |
03/27/2003 | CA2453961A1 Concentration of protein and/or peptides samples |
03/27/2003 | CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma |
03/27/2003 | CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
03/27/2003 | CA2425784A1 Diagnostic markers for ischemia |
03/27/2003 | CA2425781A1 Early diagnosis of stroke |
03/26/2003 | EP1296334A2 Associative memory with matching circuit with differential amplification |
03/26/2003 | EP1296143A2 Mass spectrometric detection of polypeptides |
03/26/2003 | EP1296142A2 Calcium receptor active molecules |
03/26/2003 | EP1296141A1 Biosensor |
03/26/2003 | EP1296140A1 Method of evaluating binding activity of ligand to ligand-binding protein |
03/26/2003 | EP1296139A1 Micro-array of organism-associated substance |
03/26/2003 | EP1296138A1 Use of disease-associated gene |
03/26/2003 | EP1296137A2 Dough measurement for monitoring and controlling the dough quality in automatic dough processing |
03/26/2003 | EP1295952A2 Methods for screening for transdominant effector peptides and RNA molecules |
03/26/2003 | EP1295947A1 Method of measuring total homocysteine |
03/26/2003 | EP1295897A1 DNA encoding the chimpanzee prostaglandin E2 receptor EP4 subtype |
03/26/2003 | EP1295896A1 Method for identifying or isolating a molecule and molecules identified thereby |
03/26/2003 | EP1295893A1 SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1 |
03/26/2003 | EP1295670A2 Nondestructive inspection method |
03/26/2003 | EP1295643A1 Liquid droplet ejecting method and a liquid droplet ejection apparatus |
03/26/2003 | EP1295635A1 Pin plate for use in array printing and method for making the pin plate |
03/26/2003 | EP1295610A2 Crystals of free and antibiotic complexed large ribosomal subunits |
03/26/2003 | EP1295243A2 System for identifying clusters in scatter plots using smoothed polygons with optimal boundaries |
03/26/2003 | EP1295131A2 Process for the measurement of non-transferrin bound iron |
03/26/2003 | EP1295129A1 Differential diagnosis of neurological diseases |
03/26/2003 | EP1295128A2 Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit |
03/26/2003 | EP1295127A2 Inter-alpha-trypsin as a marker for sepsis |
03/26/2003 | EP1295126A2 Hepatitis c viral antigen immunoassay detection systems |
03/26/2003 | EP1295125A1 Immunological test and diagnostic kit for prostate adenocarcinoma |
03/26/2003 | EP1295124A1 Competitive assay method |
03/26/2003 | EP1295123A1 Selective labeling and isolation of phosphopeptides and applications to proteome analysis |
03/26/2003 | EP1295122A2 Ipg assay |
03/26/2003 | EP1295121A1 A bioluminescence resonance energy transfer (bret) system with broad spectral resolution between donor and acceptor emission wavelengths and its use |
03/26/2003 | EP1295120A2 Agonist versus antagonist binding to g protein-coupled receptors |
03/26/2003 | EP1295119A2 Scanning kelvin microprobe system and process for analyzing a surface |
03/26/2003 | EP1295117A1 Sensor for helium or hydrogen |
03/26/2003 | EP1295113A2 Non-thermosensitive medium for analysing species inside a channel |
03/26/2003 | EP1295112A1 Positive identification of samples analysed by electrophoresis on a porous support |
03/26/2003 | EP1295106A1 Non-dispersive ir measurement of gases using an optical filter |
03/26/2003 | EP1295104A1 Method and apparatus for rapid fat content determination |
03/26/2003 | EP1295091A1 Method for predicting flow properties of powders |
03/26/2003 | EP1294952A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
03/26/2003 | EP1294951A2 Diagnosis of diseases associated with the immune system |
03/26/2003 | EP1294950A2 Diagnosis of diseases associated with development genes |
03/26/2003 | EP1294949A2 Human tumor necrosis factor delta and epsilon |
03/26/2003 | EP1294948A2 Diagnosis of behavioural disorders, neurological disorders and cancer |
03/26/2003 | EP1294947A2 Method and nucleic acids for pharmacogenomic methylation analysis |
03/26/2003 | EP1294945A2 Method for detecting cytosine methylations |
03/26/2003 | EP1294944A2 Detection of nucleic acids by type-specific hybrid capture method |
03/26/2003 | EP1294940A2 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis |
03/26/2003 | EP1294931A1 Screening methods for gram-positive enterococcal virulence factors |
03/26/2003 | EP1294930A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |
03/26/2003 | EP1294928A1 Screening method for modulators of suv39h2-methyltransferase |
03/26/2003 | EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
03/26/2003 | EP1294923A2 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen |
03/26/2003 | EP1294906A2 Whole-body optical imaging of gene expression and uses thereof |
03/26/2003 | EP1294891A2 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof |
03/26/2003 | EP1294888A2 Interferon-like protein zcyto21 |